Exosomes derived from Baicalin-pretreated bone mesenchymal stem cells improve Th17/Treg imbalance after hepatic ischemia-reperfusion via FGF21 and the JAK2/STAT3 pathway.
Baicalin-preteated BMSC-derived exosomes reduce hepatic I/R injury by suppressing inflammation, improving cell balance, and inducing FGF21 expression. Baicalin enhances therapeutic potential of exosomes for liver damage.
- Zhang B et al (2024).
- IUBMB Life.
- DOI:
- 10.1002/iub.2810
- PubMed:
- 38380586